-
1.
公开(公告)号:US20120093850A1
公开(公告)日:2012-04-19
申请号:US13234077
申请日:2011-09-15
申请人: Fabio BAGNOLI , Massimiliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
发明人: Fabio BAGNOLI , Massimiliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
IPC分类号: A61K39/085 , C12N9/52 , C12N9/02 , C12N9/16 , A61P31/04 , C12N9/20 , C12N9/14 , A61K39/385 , C12N15/31 , A61P37/04 , C07K14/31 , C12N9/10
CPC分类号: A61K39/085 , A61K39/00 , C07K14/31 , C07K2319/00
摘要: Staphylococcus aureus Hla polypeptides having various deletions, insertions, and/or mutations which are useful for immunisation are provided herein. Also provided herein are Hla heptamers which are non-haemolytic. Additionally, an effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens, including Hla polypeptides having deletions, insertions, and/or mutations, are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
摘要翻译: 具有可用于免疫的各种缺失,插入和/或突变的金黄色葡萄球菌Hla多肽在本文中提供。 本文还提供了非溶血性的Hla七聚体。 此外,有效的金黄色葡萄球菌疫苗可能需要几种抗原成分,因此确定金黄色葡萄球菌抗原(包括具有缺失,插入和/或突变的Hla多肽)的各种组合用于免疫。 这些多肽可以任选地与金黄色葡萄球菌组合使用。
-
公开(公告)号:US08679505B2
公开(公告)日:2014-03-25
申请号:US13264369
申请日:2010-04-14
申请人: Fabio Bagnoli , Massimiliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
发明人: Fabio Bagnoli , Massimiliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
IPC分类号: A61K39/085 , C07K14/31 , C07H21/00
CPC分类号: A61K39/085 , A61K39/00 , C07K14/31 , C07K2319/00
摘要: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.
摘要翻译: 有效的金黄色葡萄球菌疫苗可能需要几种抗原成分,因此鉴定出金黄色葡萄球菌抗原的各种组合用于免疫。 这些多肽可以任选地与金黄色葡萄球菌组合使用。
-
3.
公开(公告)号:US20120107340A1
公开(公告)日:2012-05-03
申请号:US13264369
申请日:2010-04-14
申请人: Fabio Bagnoli , Massimilliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
发明人: Fabio Bagnoli , Massimilliano Biagini , Luigi Fiaschi , Guido Grandi , Ravi Pratap Narayan Mishra , Nathalie Norais , Maria Scarselli
IPC分类号: A61K39/085 , A61P31/04 , C07H21/00 , A61P37/04 , A61K39/385 , C07K14/31
CPC分类号: A61K39/085 , A61K39/00 , C07K14/31 , C07K2319/00
摘要: An effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens are identified for use in immunisation. These polypeptides may optionally be used in combination with S. aureus saccharides.
摘要翻译: 有效的金黄色葡萄球菌疫苗可能需要几种抗原成分,因此鉴定出金黄色葡萄球菌抗原的各种组合用于免疫。 这些多肽可以任选地与金黄色葡萄球菌组合使用。
-
公开(公告)号:US08632783B2
公开(公告)日:2014-01-21
申请号:US13234077
申请日:2011-09-15
申请人: Fabio Bagnoli , Luigi Fiaschi
发明人: Fabio Bagnoli , Luigi Fiaschi
IPC分类号: A61K39/085 , C07H21/04 , C07K14/31
CPC分类号: A61K39/085 , A61K39/00 , C07K14/31 , C07K2319/00
摘要: Staphylococcus aureus Hla polypeptides having various deletions, insertions, and/or mutations which are useful for immunization are provided herein. Also provided herein are Hla heptamers which are non-haemolytic. Additionally, an effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens, including Hla polypeptides having deletions, insertions, and/or mutations, are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.
摘要翻译: 具有可用于免疫的各种缺失,插入和/或突变的金黄色葡萄球菌Hla多肽在本文中提供。 本文还提供了非溶血性的Hla七聚体。 此外,有效的金黄色葡萄球菌疫苗可能需要几种抗原成分,因此确定金黄色葡萄球菌抗原(包括具有缺失,插入和/或突变的Hla多肽)的各种组合用于免疫。 这些多肽可以任选地与金黄色葡萄球菌组合使用。
-
-
-